Chronic Recurrent Parotitis
Conditions
Interventions
Control Group:Control Group: Oral antibiotics (bacterial culture + drug sensitivity test), combined with topical application of Golden Detoxification Ointment, gargling with equal amounts of Honeysuck
Treatment group:Based on TCM etiology and pathogenesis, divided into Liver-Stomach Disharmony Syndrome and Qi-Blood Deficiency Syndrome. On the basis of the control group, use Liver-Soothing Heat-Clea
Sponsors
Hebei Provincial Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Western diagnostic criteria (CRP standards from 8th Edition of Oral and Maxillofacial Surgery, People's Medical Publishing House 2020): 1. Recurrent unilateral/bilateral parotid swelling/pain aggravated by eating 2. Red swollen duct orifice with gelatinous/purulent discharge upon gland compression 3. Asymptomatic interphase with reduced saliva output, occasionally turbid secretions 4. Sialography showing punctate/globular dilatation of terminal ducts with delayed contrast excretion TCM syndrome differentiation criteria: 1. Liver-Stomach Disharmony Syndrome Manifestations: Recurrent gland swelling, salty taste, viscous/purulent morning discharge, hypochondriac distension, bitter mouth, wiry pulse 2. Qi-Blood Deficiency Syndrome Manifestations: Indurated gland swelling, thin purulent discharge, sallow complexion, lassitude, loose stool, deep-thin pulse Inclusion criteria: 1. Meet above diagnostic standards 2. Age 18-65 years 3. No recent drug interventions or severe comorbidities 4. Compliance with protocol and informed consent
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1. Non-conforming to inclusion criteria 2. History of other salivary gland diseases 3. Chronic obstructive parotitis from calculi 4. Severe systemic diseases/uncontrolled hypertension/diabetes 5. Concurrent anti-inflammatory/confounding medications 6. Allergies to study medications 7. Pregnancy/lactation 8. Investigator-deemed ineligibility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical Efficacy;inflammatory factor; | — |
Countries
China
Contacts
Public ContactWang Shuangshuang
Hebei Provincial Traditional Chinese Medicine Hospital
Outcome results
None listed